Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
EnaraBio Ltd, The Bellhouse Building, Oxford Science Park, Sanders Road, Oxford, OX44GD, UK.
EMBO J. 2024 Jan;43(1):132-150. doi: 10.1038/s44318-023-00012-1. Epub 2023 Dec 18.
Understanding cellular decisions due to receptor-ligand interactions at cell-cell interfaces has been hampered by the difficulty of independently varying the surface density of multiple different ligands. Here, we express the synthetic binder protein SpyCatcher, designed to form spontaneous covalent bonds with interactors carrying a Spytag, on the cell surface. Using this, we show that addition of different concentrations and combinations of native Spytag-fused ligands allows for the combinatorial display of ligands on cells within minutes. We use this combinatorial display of cell surface ligands-called CombiCells-to assess T cell antigen sensitivity and the impact of T cell co-stimulation and co-inhibition receptors. We find that the T cell receptor (TCR) displayed greater sensitivity to peptides on major-histocompatibility complexes (pMHC) than synthetic chimeric antigen receptor (CARs) and bi-specific T cell engager (BiTEs) display to their target antigen, CD19. While TCR sensitivity was greatly enhanced by CD2/CD58 interactions, CAR sensitivity was primarily but more modestly enhanced by LFA-1/ICAM-1 interactions. Lastly, we show that PD-1/PD-L1 engagement inhibited T cell activation triggered solely by TCR/pMHC interactions, as well as the amplified activation induced by CD2 and CD28 co-stimulation. The ability to easily produce cells with different concentrations and combinations of ligands should accelerate the study of receptor-ligand interactions at cell-cell interfaces.
由于细胞-细胞界面上受体-配体相互作用,细胞做出决定的过程一直受到多种不同配体的表面密度难以独立变化的阻碍。在这里,我们在细胞表面表达了一种合成结合蛋白 SpyCatcher,该蛋白设计用于与带有 Spytag 的相互作用者形成自发的共价键。利用这一点,我们表明,添加不同浓度和组合的天然 Spytag 融合配体可以在数分钟内实现细胞表面配体的组合展示。我们将这种细胞表面配体的组合展示称为 CombiCells,用于评估 T 细胞抗原敏感性以及 T 细胞共刺激和共抑制受体的影响。我们发现,T 细胞受体(TCR)对主要组织相容性复合物(pMHC)上的肽的敏感性高于合成嵌合抗原受体(CAR)和双特异性 T 细胞衔接器(BiTE)对其靶抗原 CD19 的敏感性。虽然 TCR 敏感性通过 CD2/CD58 相互作用得到了极大增强,但 CAR 敏感性主要是但更适度地通过 LFA-1/ICAM-1 相互作用增强。最后,我们表明,PD-1/PD-L1 结合抑制了仅由 TCR/pMHC 相互作用触发的 T 细胞激活,以及由 CD2 和 CD28 共刺激引发的放大激活。能够轻松生产具有不同浓度和组合配体的细胞的能力,应该会加速细胞-细胞界面上受体-配体相互作用的研究。